The'revolutionary' cancer-killing virus was injected into the first human.

The'revolutionary' cancer-killing virus was injected into the first human.

According to scientists, the first human patient has been injected with Vaxinia, a "revolutionary" cancer-killing virus that has previously been successfully employed on animals.

According to BGR, scientists expect that the virus will boost the immune system's response to better combat cancer cells.

Vaxinia was created to kill cancer cells and has shown encouraging results in animal testing.

The researchers ensured that the virus was not only cancer-killing, but also able to make it more recognised to the immune system in this current trial. In Phase 1, the vaccination is being studied on 100 patients with a metastatic or advanced solid tumour who have already tried at least two different treatments.

The medicine will be given to two groups: one will receive Vaxinia, while the other will receive the cancer-killing virus along with an immunotherapy drug.

Phase 1 is primarily concerned with maintaining safety and establishing the proper dose, therefore they do not provide the intended outcomes right away.

When scientists tested the virus on animals, it was able to decrease the tumour in the studies, which was a huge success. While a successful animal experiment does not guarantee a positive outcome in human trials, experts are hoping that this will open up new avenues for the body to fight cancer. By 2025, the study is projected to be completed.